Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer: Effects Modified by Plasma Antioxidants
Authors:
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American MenCancer Research, 2008
- Plasma Carotenoids and Prostate Cancer: A Population-Based Case-Control Study in ArkansasNutrition and Cancer, 2007
- Racial differences in clinical and pathological associations with PhIP‐DNA adducts in prostateInternational Journal of Cancer, 2007
- Polymorphisms of DNA repair genes are risk factors for prostate cancerEuropean Journal of Cancer, 2007
- The Use of Genetic Markers to Determine Risk for Prostate Cancer at Prostate BiopsyClinical Cancer Research, 2005
- Molecular pathology of prostate cancerJournal of Clinical Pathology, 2005
- CYP3A43 Pro340Ala Polymorphism and Prostate Cancer Risk in African Americans and CaucasiansCancer Epidemiology, Biomarkers & Prevention, 2005
- Prostatitis as a Risk Factor for Prostate CancerEpidemiology, 2004
- Association Between Polymorphism of Human Oxoguanine Glycosylase 1 and Risk of Prostate CancerJournal of Urology, 2003
- Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNAOncogene, 1998